v3.21.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 14,490,745 $ 14,223,917
Accounts receivable, net 968,107 1,080,656
Prepaid expenses and other current assets 514,417 415,915
Inventories, net 1,676,532 2,420,179
Advances on contracts 1,509,530 414,202
Total current assets 19,159,331 18,554,869
Furniture, fixtures and equipment, net 27,139 30,729
Intangibles, net 295,189 329,249
Right of use assets 571,678 632,453
Other assets 24,150 24,150
Total assets 20,077,487 19,571,450
Current liabilities:    
Accounts payable 743,879 482,972
Accounts payable, related party 420,251 385,138
Accrued expenses and other payables 1,335,755 824,454
Accrued expenses, related party 535,481 586,734
Current portion of finance leases liabilities 8,351 7,796
Current portion of operating lease right-of-use liabilities 78,476 72,031
Deferred profit, related party 407,050 242,589
Note payable 0 276,180
Total current liabilities 3,529,243 2,877,894
Finance lease liabilities 22,273 28,607
Operating lease liabilities 497,932 557,981
Total liabilities 4,049,448 3,464,482
Commitments and contingencies
Stockholders’ equity    
Common stock, par value $.001; authorized 100,000,000 shares; 67,610,864 shares issued and 67,577,531 shares outstanding as of September 30, 2021; 64,171,435 shares issued and 64,138,102 shares outstanding as of December 31, 2020; 67,610 64,171
Additional paid in capital 123,590,412 117,934,696
Accumulated deficit (106,582,501) (100,885,957)
Treasury stock, at cost, 33,333 shares (911,516) (911,516)
Total Milestone Scientific Inc. stockholders' equity 16,164,005 16,201,394
Noncontrolling interest (135,966) (94,426)
Total stockholders’ equity 16,028,039 16,106,968
Total liabilities and stockholders’ equity $ 20,077,487 $ 19,571,450

Source